How ELF3 Overexpression and PTEN Deficiency Promote Lung Cancer
Author Information
Author(s): Yuan Zengzhuang, Han Xinyan, Xiao Manyu, Zhu Taoyu, Xu Yaping, Tang Qian, Lian Chen, Wang Zijin, Li Junming, Wang Boyu, Li Changhui, Xiang Xiaochen, Jin Ruobai, Liu Yufei, Yu Xinyu, Zhang Kehang, Li Songsong, Ray Madhumita, Li Rong, Gruzdev Artiom, Shao Shiqun, Shao Fangwei, Wang Hua, Lian Wang, Tang Yong, Chen Di, Lei Ying, Jin Xuru, Li Qinglin, Long Weiwen, Huang Huaqiong, DeMayo Francesco J.
Primary Institution: Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
Hypothesis
Does ELF3 overexpression in PTEN-deficient lung epithelium promote lung cancer development by inhibiting ferroptosis?
Conclusion
ELF3 overexpression in PTEN-deficient lung epithelium promotes lung cancer development by inhibiting ferroptosis through the induction of SCL7A11.
Supporting Evidence
- ELF3 overexpression was found to promote cell proliferation and inhibit ferroptosis.
- Human lung tumors showed a negative correlation between ELF3 and PTEN expression.
- Targeting SCL7A11 with erastin induced ferroptosis and inhibited tumor development.
Takeaway
When a protein called ELF3 is too much in lung cells that lack another protein called PTEN, it can help cancer grow by stopping a process that kills cancer cells.
Methodology
The study used genetically modified mice to investigate the effects of ELF3 overexpression in lung epithelium and analyzed gene expression through RNA sequencing.
Potential Biases
Potential bias in interpreting the correlation between ELF3 and PTEN expression in human tumors.
Limitations
The study primarily focused on mouse models, which may not fully replicate human lung cancer biology.
Participant Demographics
The study involved murine models and human lung cancer patient data.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website